DE69228539D1 - Verfahren zur klassifikation von analyten mittels konzentrations ("sc")-profilen - Google Patents

Verfahren zur klassifikation von analyten mittels konzentrations ("sc")-profilen

Info

Publication number
DE69228539D1
DE69228539D1 DE69228539T DE69228539T DE69228539D1 DE 69228539 D1 DE69228539 D1 DE 69228539D1 DE 69228539 T DE69228539 T DE 69228539T DE 69228539 T DE69228539 T DE 69228539T DE 69228539 D1 DE69228539 D1 DE 69228539D1
Authority
DE
Germany
Prior art keywords
analyte
profiles
samples
databank
tested
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69228539T
Other languages
English (en)
Inventor
Lawrence Kauvar
Stuart Ambler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telik Inc
Original Assignee
Telik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telik Inc filed Critical Telik Inc
Application granted granted Critical
Publication of DE69228539D1 publication Critical patent/DE69228539D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/816—Alkaloids, amphetamines, and barbiturates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/901—Drugs of abuse, e.g. narcotics, amphetamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DE69228539T 1991-04-02 1992-04-02 Verfahren zur klassifikation von analyten mittels konzentrations ("sc")-profilen Expired - Lifetime DE69228539D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/678,849 US5338659A (en) 1991-04-02 1991-04-02 Method for determining analyte concentration by cross-reactivity profiling
PCT/US1992/002716 WO1992017784A1 (en) 1991-04-02 1992-04-02 Method for analyte classification by sc profiles

Publications (1)

Publication Number Publication Date
DE69228539D1 true DE69228539D1 (de) 1999-04-08

Family

ID=24724540

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228539T Expired - Lifetime DE69228539D1 (de) 1991-04-02 1992-04-02 Verfahren zur klassifikation von analyten mittels konzentrations ("sc")-profilen

Country Status (8)

Country Link
US (2) US5338659A (de)
EP (1) EP0581881B1 (de)
JP (1) JP3101323B2 (de)
AT (1) ATE177207T1 (de)
AU (1) AU662001B2 (de)
CA (1) CA2107474C (de)
DE (1) DE69228539D1 (de)
WO (1) WO1992017784A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338659A (en) * 1991-04-02 1994-08-16 Terrapin Technologies, Inc. Method for determining analyte concentration by cross-reactivity profiling
EP0692096A1 (de) * 1993-03-30 1996-01-17 Terrapin Technologies, Inc. Verfahren zum bestimmen der konzentration durch affinitätstitrierung und kompetitive verdrängung arzmittel verabreichung
US5356784A (en) * 1993-03-30 1994-10-18 Terrapin Technologies, Inc. Determination of concentration by affinity titration
DK1235072T3 (da) * 1994-01-06 2007-07-16 Telik Inc Surrogater for målmolekyler og forbedrede referencefelter
US5587293A (en) * 1994-01-06 1996-12-24 Terrapin Technologies, Inc. Method to identify binding partners
EP0821232A1 (de) * 1996-07-24 1998-01-28 SY-LAB Vertriebsges.m.b.H. Verfahren zur Bestimmung von Bestandteilen einer Probe und Vorrichtung zur Durchführung des Verfahrens
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
AU8678198A (en) * 1997-08-01 1999-02-22 Novalon Pharmaceutical Corporation Method of identifying and developing drug leads
NZ504483A (en) 1997-11-12 2002-11-26 Dimensional Pharm Inc High throughput method for functionally classifying proteins by contacting the protein with different molecules and determining the effect on the proteins stability
US20020028469A1 (en) * 1997-11-14 2002-03-07 Burch Ronald M. Method of defining genus of chemical compound and method of designing molecules
AU1925699A (en) * 1997-12-18 1999-07-05 Sepracor, Inc. Methods for the simultaneous identification of novel biological targets and leadstructures for drug development
CN1192102C (zh) 1998-01-23 2005-03-09 新生物生物公司 酶催化的治疗剂
US7462605B2 (en) * 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
US6569631B1 (en) 1998-11-12 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Microplate thermal shift assay for ligand development using 5-(4″dimethylaminophenyl)-2-(4′-phenyl)oxazole derivative fluorescent dyes
US6453241B1 (en) * 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
JP4949560B2 (ja) * 1999-05-14 2012-06-13 ブランディーズ・ユニバーシティ 核酸をベースとする検出
US6680377B1 (en) * 1999-05-14 2004-01-20 Brandeis University Nucleic acid-based detection
JP4543187B2 (ja) * 1999-06-18 2010-09-15 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 薬物候補物に関連する薬物動態パラメータ推定のための薬物候補物のアッセイのための方法および装置
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
JP2003525866A (ja) 1999-07-22 2003-09-02 ニューバイオティックス インコーポレイテッド 治療抵抗性腫瘍を処置するための方法
WO2001020043A1 (en) * 1999-09-17 2001-03-22 Affymetrix, Inc. Method of cluster analysis of gene expression profiles
CA2408148A1 (en) * 2000-05-05 2001-11-15 United States Army Medical Research And Materiel Command Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof
DE10040289A1 (de) * 2000-08-17 2002-02-28 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung und Ermittlung geeigneter Effektoren von Zielmolekülen mit Substanzbibliotheken
EP1327148B1 (de) * 2000-10-17 2009-04-15 Bio-Rad Laboratories, Inc. Mustererkennungsverfahren zur diagnose von systemischen autoimmunerkrankungen
GB0224446D0 (en) * 2002-10-21 2002-11-27 Univ Cambridge Tech Affinity adsorbents for immunoglobulins
WO2005057169A2 (en) * 2003-12-05 2005-06-23 Trellis Bioscience, Inc. Homogeneous competition assays
US7229782B1 (en) 2004-08-03 2007-06-12 Labone, Inc. Antibodies specific to multiple beta blockers and methods for their use
GB0604236D0 (en) * 2006-03-02 2006-04-12 Prometic Biosciences Ltd Adsorbents for protein purification
WO2008106653A1 (en) * 2007-03-01 2008-09-04 Invitrogen Corporation Immunoassay for cross-reacting substances
EP3136098B1 (de) 2014-04-23 2020-12-09 Konica Minolta, Inc. Medium für harzteilchen mit fluoreszierendem farbstoff
US10054543B2 (en) 2016-02-23 2018-08-21 The United States Of America, As Represented By The Secretary Of The Army Multi-dimensional cross-reactive array for chemical sensing
US9973143B1 (en) 2016-09-01 2018-05-15 Daniel J Courselle Solar panel roof modules
CN109187779A (zh) * 2018-08-29 2019-01-11 四川百特芳华医药科技有限公司 一种甾体化合物的分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81722T1 (de) * 1984-07-24 1992-11-15 Coselco Mimotopes Pty Ltd Verfahren zur bestimmung von mimotopen.
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US5300425A (en) * 1987-10-13 1994-04-05 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US5338659A (en) * 1991-04-02 1994-08-16 Terrapin Technologies, Inc. Method for determining analyte concentration by cross-reactivity profiling
ATE152244T1 (de) * 1987-10-13 1997-05-15 Terrapin Tech Inc Verfahren zur herstellung von imunodiagnose- mitteln

Also Published As

Publication number Publication date
CA2107474C (en) 2002-06-11
AU662001B2 (en) 1995-08-17
EP0581881B1 (de) 1999-03-03
ATE177207T1 (de) 1999-03-15
WO1992017784A1 (en) 1992-10-15
JP3101323B2 (ja) 2000-10-23
EP0581881A4 (en) 1994-07-06
US5674688A (en) 1997-10-07
AU1987892A (en) 1992-11-02
US5338659A (en) 1994-08-16
EP0581881A1 (de) 1994-02-09
JPH06509865A (ja) 1994-11-02
CA2107474A1 (en) 1992-10-03

Similar Documents

Publication Publication Date Title
DE69228539D1 (de) Verfahren zur klassifikation von analyten mittels konzentrations ("sc")-profilen
DE69904956T2 (de) Testsatz und verfahren zur qualitätsprüfung von einem iontophoretischen probenahmesystem
NZ502821A (en) Method and apparatus for generating analyte basis sets for use in spectroscopic analysis
DE59309071D1 (de) Verfahren zur analytischen Bestimmung der Konzentration eines Bestandteils einer medizinischen Probe
YU46053B (sh) Postopek za specifično določanje vsebnosti serumskega fruktozamina
ATE185423T1 (de) Verfahren zur analyse eines bestandteils einer medizinischen probe
ATE333091T1 (de) Verfahren zur messung von blutersatzstoffen
DE60325107D1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
DE59712670D1 (de) Verfahren zur instrumentellen Bestimmung einer sich zeitabhängig ändernden Messgrösse
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür
DE69026006D1 (de) Enzymatisches Verfahren zur Bestimmung der Analyt-Konzentration
DE3782715D1 (de) Verfahren zur bestimmung des konzentrationsverhaeltnisses von lithiumionen zu natriumionen und vorrichtung zur durchfuehrung dieses verfahrens.
ATE204079T1 (de) Verfahren zur spektralanalyse von inhomogenen proben
ATE295537T1 (de) Testverfahren zum nachweiss von lipoproteinen
DE3786385D1 (de) Verfahren zur analyse von wasser sowie vorrichtung zur durchfuehrung dieses verfahrens.
KR960018583A (ko) 면역 분석법
ATE93059T1 (de) Verfahren zur verbesserung von richtigkeit und reproduzierbarkeit der messdaten immunometrischer tests.
SU1622804A1 (ru) Способ количественного рентгенофлуоресцентного анализа
ATE199781T1 (de) Verfahren zur beseitigung von hämoglobin- störungen bei der bestimmung von albumin
ES2129411T3 (es) Metodo para evaluar la adecuacion de especimenes clinicos para ensayos de hibridacion y estuche para realizar la evaluacion.
KR960024345A (ko) 여지법을 이용한 용액중의 미량 염소이온 형과 x-선 분석방법
DE69420308D1 (de) Indikatorreagenzien zum Nachweis oder zur Messung von Analyten, Testsatz, der diese enthält, und Verfahren zum Nachweis oder zur Messung
TH29461B (th) "เครื่องมือสำหรับการตรวจวัดด้วยแม่เหล็กความไวสูงสุดของงานวิเคราะห์"
ATE57022T1 (de) Verfahren zur bestimmung von parathormon.

Legal Events

Date Code Title Description
8332 No legal effect for de